Summit Therapeutics PLC (SMMT : NASDAQ)
Common Stock
$15.55
USD
-0.28 (-1.77%)
Last updated: 2026-10-22
Follow SMMT
SMMT
Summit Therapeutics PLC
WealthAwesomePerformance
1 Day
-1.77%
1 Week
+1.17%
1 Month
-9.17%
YTD
+10.52%
Key Statistics
Market Cap
$12.63B
52W High
$29.23
52W Low
$12.07
P/E Ratio
-
50 Day MA
$15.75
200 Day MA
$16.27
Beta
-1.52
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/22/2026 | $15.29 | $15.70 | $15.13 | $15.55 | $15.55 | 4,134,785 |
| 10/21/2026 | $16.35 | $16.35 | $15.72 | $15.83 | $15.83 | 5,362,982 |
| 10/20/2026 | $15.50 | $16.18 | $15.06 | $16.09 | $16.09 | 6,250,500 |
| 10/19/2026 | $14.90 | $15.77 | $14.83 | $15.57 | $15.57 | 6,152,600 |
| 10/16/2026 | $15.39 | $15.41 | $14.56 | $14.63 | $14.63 | 4,316,200 |
| 10/15/2026 | $15.09 | $15.55 | $15.08 | $15.37 | $15.37 | 4,722,413 |
| 10/14/2026 | $15.29 | $15.56 | $15.04 | $15.13 | $15.13 | 4,648,530 |
| 10/13/2026 | $16.79 | $16.79 | $15.46 | $15.52 | $15.52 | 7,104,927 |
| 10/12/2026 | $17.48 | $17.59 | $17.05 | $17.13 | $17.13 | 4,368,939 |
| 10/9/2026 | $17.36 | $17.62 | $16.82 | $17.59 | $17.59 | 5,751,500 |
Analyst Price Targets
Based on 17 analysts covering SMMT · as of Oct 23, 2026
Wall Street analysts forecast SMMT stock price to rise 94.7% over the next 12 months.
Consensus
Buy4.24 / 5.00
Avg. Target
US$30.28
+94.7% Upside
Previously US$30.35 on Oct 22, 2026
Current Price
US$15.55
Last close
Analyst Breakdown (17 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SMMT's historical volatility
30-Day Vol
60.9%
Annualized
90-Day Vol
65.7%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$18.59
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$16.50 | US$13.38 – US$20.36 |
| 60 trading days | US$17.52 | US$13.01 – US$23.58 |
| 90 trading days | US$18.59 | US$12.92 – US$26.75 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Summit Therapeutics PLC
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical trial for the patients with epidermal growth factor receptor, mutated, and locally advanced or metastatic non-squamous NSCLC; first-line metastatic NSCLC; and first-line unresectable metastatic CRC. It markets its products in the United states, Canada, Europe, Japan, Latin America, Middle East, and Africa. The company was founded in 2003 and is headquartered in Miami, Florida.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-874.67M
- Profit Margin
- 0.00%
- ROE (TTM)
- -192.51%
- EPS (Diluted)
- -1.11
- Book Value
- 0.79
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About SMMT.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| HCAI | Huachen AI Parking Management Technology Holding Co Ltd | $3.30 | +1365.19% |
| NVNI | Nvni Group Limited Ordinary Shares | $0.53 | +1224.94% |
| HVII | Hennessy Capital Investment Corp. VII Ordinary Shares | $4.46 | +227.94% |
| TANH | Tantech Holdings Ltd | $24.83 | +181.84% |
| SHFS | SHF Holdings Inc | $0.34 | +122.37% |
| XLAB | Exascale Labs Holdings Inc. Class A Common Stock | $4.71 | +73.16% |
| STAK | STAK Inc. Ordinary Shares | $1.67 | +67.00% |
| PASW | Ping An Biomedical Co., Ltd. | $5.40 | +46.85% |
SMMT.US news timeline
3 articles covering SMMT.US, most recent first
Latest